Andrea DiFabio, Chief Legal Officer at Xenon Pharmaceuticals Inc. (XENE), sold 5,214 shares at $60.11 ($313K) on 2026-03-10, disclosed to the SEC on 2026-03-11.
Open-market sale of $313k XENE by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.11 | 2,607 | $157K | 50.0% |
| 2 | $60.11 | 2,607 | $157K | 50.0% |
| Total | $60.11 avg | 5,214 | $313K | 100% |